LUNG logo

Pulmonx (LUNG)

Profile

Full Name

Pulmonx Corporation

Ticker Symbol

LUNG

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 1, 2020

Indexes

Not included

Website

http://pulmonx.com

Employees

291

Key Details

Price

$5.19(-0.19%)

Market cap

$206.54M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$83.79M(+22.01% YoY)

Annual EPS

-$1.44(+10.00% YoY)

PE ratio

-

Next earnings date

Apr 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.19
LUNG price is $5.19

30-Day Relative Volume

0.77
LUNG 30-day relative volume is 0.77

Price Performance

Price Most recent change

-0.19%
LUNG price was down -0.19% on Apr 28, 2025

Price YTD change

-23.56%
LUNG price is down -23.56% since January 1st

Price 1-year change

-30.8%
LUNG price is down -30.8% year-on-year

Price 3-year change

-78.46%
LUNG price is down -78.46% over the past 3 years

Price Range

Price All-time high

$69.48
LUNG price is currently -92.53% below its historical high of $69.48

Price 3-year low

$4.07
LUNG price is currently +27.52% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$206.54M
LUNG market capitalization is $206.54 million

Market cap 3-year change

-76.9%
LUNG market capitalization is down -76.9% over the past 3 years

Market cap All-time high

$2.46B
LUNG market capitalization is currently -91.62% below its historical high of $2.46 billion

Market cap sector rank

56.1%
LUNG market capitalization is higher than 56.1% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.54%
LUNG shares outstanding is up +2.54% year-on-year

Shares Outstanding 3-Year Change

+7.27%
LUNG shares outstanding is up +7.27% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.54
LUNG beta is 0.54

200-day SMA

$6.85
LUNG price is currently -24.22% below its 200-day simple moving average

50-day SMA

$6.88
LUNG price is currently -24.58% below its 50-day simple moving average

RSI

37.71
LUNG 14-day relative strength index is 37.71

Volume

0.77
LUNG 30-day relative volume is 0.77

ATR

$0.45
LUNG average true range is $0.45

10-day Historical Volatility

73.91%
LUNG 10-day historical volatility is 73.91%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$83.79M
LUNG annual revenue is $83.79 million

Revenue Analysts estimate

$96.98M
LUNG annual revenue is currently -13.60% lower than the consensus analysts' forecast

Revenue 1-year change

+22.01%
LUNG annual revenue is up +22.01% year-on-year

Revenue Sector rank

54.38%
LUNG annual revenue is higher than 54.38% of companies in Healthcare sector

EPS

EPS

-$1.44
LUNG annual earnings per share is -$1.44

EPS Analysts estimate

-$1.55
LUNG annual earnings per share is currently -6.89% lower than the consensus analysts' forecast

EPS 1-year change

+10%
LUNG annual earnings per share is up +10% year-on-year

EPS Sector rank

46.43%
LUNG annual earnings per share is higher than 46.43% of companies in Healthcare sector

Profit

Gross profit

$62.00M
LUNG annual gross profit is $62.00 million

Gross margin

74.00%
LUNG annual gross profit margin is 74.00%

Operating profit

-$57.70M
LUNG annual operating income is -$57.70 million

Operating margin

-68.87%
LUNG annual operating profit margin is -68.87%

Net income

-$56.39M
LUNG annual net profit is -$56.39 million

Net margin

-67.30%
LUNG annual net profit margin is -67.30%

Expenses

Total expenses

$141.49M
LUNG annual total expenses is $141.49 million

Operating expenses

$119.70M
LUNG annual total operating expenses is $119.70 million

Cost of goods sold

$21.79M
LUNG annual cost of goods sold is $21.79 million

Selling, general & administrative expenses

$102.14M
LUNG annual SGA is $102.14 million

Depreciation and amortization

$1.49M
LUNG annual depreciation & amortization is $1.49 million

Interest expense

$3.51M
LUNG annual interest expense is $3.51 million

Income tax

$500.00K
LUNG annual income tax is $500.00 thousand

EBIT & EBITDA

EBIT

-$52.39M
LUNG annual earnings before interest & taxes is -$52.39 million

EBITDA

-$52.39M
LUNG annual EBITDA is -$52.39 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$162.85M
LUNG annual total assets is $162.85 million

Non current assets

$26.60M
LUNG annual long term assets is $26.60 million

Current assets

$136.25M
LUNG annual total current assets is $136.25 million

Cash and cash equivalents

$70.91M
LUNG annual cash & cash equivalents is $70.91 million

Accounts receivable

$13.12M
LUNG annual accounts receivable is $13.12 million

Inventory

$16.91M
LUNG annual inventory is $16.91 million

Liabilities

Total liabilities

$77.04M
LUNG annual total liabilities is $77.04 million

Long term liabilities

$52.60M
LUNG annual total long term liabilities is $52.60 million

Current liabilities

$24.44M
LUNG annual total current liabilities is $24.44 million

Accounts payable

$3.83M
LUNG annual accounts payable is $3.83 million

Debt

Total debt

$56.47M
LUNG annual total debt is $56.47 million

Total debt 1-year change

+36.32%
LUNG annual total debt is up +36.32% year-on-year

Long term debt

$52.52M
LUNG annual long term debt is $52.52 million

Short term debt

$3.95M
LUNG annual short term debt is $3.95 million

Equity & Capital

Shareholders equity

$85.81M
LUNG annual stockholders equity is $85.81 million

Book value

$85.81M
LUNG annual book value is $85.81 million

Retained earnings

-$467.56M
LUNG annual retained earnings is -$467.56 million

Working capital

$111.81M
LUNG annual working capital is $111.81 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$31.54M
LUNG annual cash flow from operations is -$31.54 million

Cash from operations 1-year change

+16.15%
LUNG annual cash flow from operations is up +16.15% year-on-year

Cash from investing

$17.48M
LUNG annual cash flow from investing activities is $17.48 million

Cash from investing 1-year change

+970.75%
LUNG annual cash flow from investing activities is up +970.75% year-on-year

Cash from financing

$1.36M
LUNG annual cash flow from financing activities is $1.36 million

Cash from financing 1-year change

-93.63%
LUNG annual cash flow from financing activities is down -93.63% year-on-year

CAPEX

CAPEX

$1.45M
LUNG annual capital expenditures is $1.45 million

CAPEX 1-year change

+79.31%
LUNG annual capital expenditures is up +79.31% year-on-year

Free Cash Flow

Free cash flow

-$32.98M
LUNG annual free cash flow is -$32.98 million

Free cash flow 1-year change

+14.14%
LUNG annual free cash flow is up +14.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

74.00%
LUNG annual gross profit margin is 74.00%

Operating margin

-68.87%
LUNG annual operating profit margin is -68.87%

Net margin

-67.30%
LUNG annual net profit margin is -67.30%

ROA & ROE

ROA

-33.11%
LUNG annual return on assets is -33.11%

ROE

-55.25%
LUNG annual return on equity is -55.25%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LUNG price to earnings ratio value is unknown

PE ratio Sector rank

-
LUNG price to earnings ratio is unknown

PB Ratio

PB ratio

2.41
LUNG price to book ratio is 2.41

PB ratio Sector rank

65.91%
LUNG price to book ratio is higher than 65.91% of companies in Healthcare sector

PS Ratio

PS ratio

2.47
LUNG price to sales ratio is 2.47

PS ratio Sector rank

45.22%
LUNG price to sales ratio is higher than 45.22% of companies in Healthcare sector

Enterprise value

Enterprise value

$192.11M
LUNG enterprise value is $192.11 million

Enterprise value Sector rank

57%
LUNG enterprise value is higher than 57% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.75
LUNG EV/EBITDA is -3.75

EV/EBITDA Sector rank

25.39%
LUNG EV/EBITDA is higher than 25.39% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.58
LUNG annual current ratio is 5.58

Quick ratio

4.88
LUNG annual quick ratio is 4.88

Leverage

Debt to equity

0.43
LUNG annual debt to equity ratio is 0.43

Interest coverage ratio

-14.94
LUNG annual interest coverage ratio is -14.94

Risk & Stability

Piotroski F-Score

2
LUNG piotroski f-score is 2

Altman Z-Score

-2.13
LUNG altman z-score is -2.13

Analyst ratings

Recent major analysts updates

Mar 11, 25 D. Boral Capital
Buy
Mar 10, 25 D. Boral Capital
Buy
Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 Citigroup
Neutral
Oct 31, 24 Stifel
Buy
Aug 1, 24 Wells Fargo
Equal-Weight
Aug 1, 24 Piper Sandler
Overweight
Aug 1, 24 Canaccord Genuity
Buy
Jun 4, 24 Lake Street
Buy
May 2, 24 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

OCGN logo
Ocugen (OCGN)
NGNE logo
Neurogene (NGNE)
MDWD logo
MediWound (MDWD)
ANNX logo
Annexon (ANNX)
ANIK logo
Anika Therapeutics (ANIK)
OM logo
Outset Medical (OM)
CGC logo
Canopy Growth (CGC)
enGene Holdings (ENGN)
CARGO Therapeutics (CRGX)
  • What is the ticker symbol for Pulmonx?
  • Does Pulmonx pay dividends?
  • What sector is Pulmonx in?
  • What industry is Pulmonx in?
  • What country is Pulmonx based in?
  • When did Pulmonx go public?
  • Is Pulmonx in the S&P 500?
  • Is Pulmonx in the NASDAQ 100?
  • Is Pulmonx in the Dow Jones?
  • When was Pulmonx's last earnings report?
  • When does Pulmonx report earnings?
  • Should I buy Pulmonx stock now?

What is the ticker symbol for Pulmonx?

The ticker symbol for Pulmonx is NASDAQ:LUNG

Does Pulmonx pay dividends?

No, Pulmonx does not pay dividends

What sector is Pulmonx in?

Pulmonx is in the Healthcare sector

What industry is Pulmonx in?

Pulmonx is in the Medical Devices industry

What country is Pulmonx based in?

Pulmonx is headquartered in United States

When did Pulmonx go public?

Pulmonx's initial public offering (IPO) was on October 1, 2020

Is Pulmonx in the S&P 500?

No, Pulmonx is not included in the S&P 500 index

Is Pulmonx in the NASDAQ 100?

No, Pulmonx is not included in the NASDAQ 100 index

Is Pulmonx in the Dow Jones?

No, Pulmonx is not included in the Dow Jones index

When was Pulmonx's last earnings report?

Pulmonx's most recent earnings report was on Feb 19, 2025

When does Pulmonx report earnings?

The next expected earnings date for Pulmonx is Apr 30, 2025

Should I buy Pulmonx stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page